Research Article

A Fortified Method to Screen and Detect Left Ventricular Hypertrophy in Asymptomatic Hypertensive Adults: A Korean Retrospective, Cross-Sectional Study

Table 1

Baseline characteristics of study subjects according to the presence or absence of echocardiographic left ventricular hypertrophy by LV mass.

LVH (n=168)No LVH (n=621)p value

Demographic information
 Female, n (%)80 (47.6%)122 (19.6%)<0.001
 Age, years64 ± 1059 ± 8<0.001
 Diabetes mellitus, n (%)32 (19.0%)104 (16.7%)0.558
 Hyperlipidemia, n (%)61 (36.3%)217 (34.9%)0.812
 Height, m1.63 ± 0.091.67 ± 0.07<0.001
 Weight, kg67.5 ± 11.970.1 ± 11.20.007
 BMI, kg/m225.3 ± 3.124.9 ± 2.80.058
 SBP, mmHg126.4 ± 13.2122.5 ± 13.50.001
 DBP, mmHg79.7 ± 9.581.4 ± 9.80.045
Laboratory results
 Fasting glucose, mmol/L5.83 ± 1.005.88 ± 1.110.422
 HbA1c, %5.9 ± 0.55.9 ± 0.70.342
 Total cholesterol, mmol/L4.66 ± 0.914.74 ± 0.880.335
 Triglyceride, mmol/L1.39 ± 0.751.47 ± 0.870.295
 HDL cholesterol, mmol/L1.40 ± 0.341.32 ± 0.280.012
 LDL cholesterol, mmol/L2.75 ± 0.752.90 ± 0.750.009
 BUN, mmol/L6.07 ± 2.145.71 ± 1.780.063
 Cr, μmol/L79.56 ± 17.6879.56 ± 35.360.359
Echocardiography measurement
 LVIDd, mm52 ± 448 ± 4<0.001
 LVIDs, mm30 ± 428 ± 3<0.001
 LVEF, %67 ± 667 ± 50.943
 IVSd, mm11 ± 19 ± 1<0.001
 LVPWd, mm11 ± 19 ± 1<0.001
 LV mass, g213 ± 43159 ± 33<0.001
 LV mass/BSA, g/m2122 ± 1888 ± 14<0.001
Radiology measurement
 CD, mm139.4 ± 14.3137.1 ± 14.20.067
 CTR0.48 ± 0.050.46 ± 0.04<0.001
Electrocardiography measurement
 SLVA, mm25.7 ± 8.924.1 ± 7.20.042
 CVA, mm15.5 ± 5.815.0 ± 5.80.313

BMI, body mass index; BSA, body surface area; BUN, blood urea nitrogen; CD, cardiac diameter; Cr, serum creatinine; CTR, cardiothoracic ratio; CVA, Cornell voltage amplitude; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; IVSd, interventricular septum end-diastolic thickness; LV, left ventricle; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; LVIDd, left ventricular end-diastolic diameter; LVIDs, left ventricular end-systolic diameter; LVPWd, left ventricular end-diastolic posterior wall thickness; LDL, low-density lipoprotein; SBP, systolic blood pressure; SLVA, Sokolow-Lyon voltage amplitude
<0.05
<0.01.